CD36 is also implicated in the etiology of drug resistance mechanisms to a broad range of drug classes in cancer cells via both FA metabolism-dependent and -independent fashions, further adding complexity to the role of CD36 in cancer biology. The gene discussed is CD36; the disease is cancer.